Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benoit You

Showing results (21-30 of 141) with videos related to

Pageof 15
Sort By:
Bulletin Du Cancer|June 20, 2017
Anne Floquet, Dominique Berton-Rigaud, Gwenael Ferron, et al.
Anticancer Research|December 1, 2017
Modeling CA-125 During Neoadjuvant Chemotherapy for Predicting Optimal Cytoreduction and Relapse Risk in Ovarian CancerSimon Ducoulombier, François Golfier, Olivier Colomban, et al.
Gynecologic and Obstetric Investigation|September 13, 2023
Immunotherapy for Gestational Trophoblastic Neoplasia: A New ParadigmInge O Baas, Anneke M Westermann, Benoit You, et al.
Anti-Cancer Drugs|December 11, 2012
Influence of statistician involvement on reporting of randomized clinical trials in medical oncologyJulien Péron, Benoit You, Hui K Gan, et al.
Cancers|February 15, 2022
Modeled Early Longitudinal PSA Kinetics Prognostic Value in Rising PSA Prostate Cancer Patients after Local Therapy Treated with ADT +/- DocetaxelAurore Carrot, Reza-Thierry Elaidi, Olivier Colomban, et al.
Annals of Surgical Oncology|February 8, 2023
ASO Author Reflections: Which is the Optimal Preoperative Systemic Chemotherapy Regimen for Patients with Peritoneal Metastases from Colorectal Cancer?Vahan Kepenekian, Amaniel Kefleyesus, Guillaume Passot, et al.
JCO Clinical Cancer Informatics|February 16, 2024
Prognostic Value of the Modeled Prostate-Specific Antigen KELIM Confirmation in Metastatic Castration-Resistant Prostate Cancer Treated With Taxanes in FIRSTANAAurore Carrot, Stéphane Oudard, Olivier Colomban, et al.
Annals of Surgical Oncology|June 5, 2015
Intraperitoneal Vascular Endothelial Growth Factor: A Prognostic Factor and the Potential for Intraperitoneal Bevacizumab Use in Peritoneal Surface MalignanciesClaramae Shulyn Chia, Olivier Glehen, Naoual Bakrin, et al.
Annals of Surgery|May 15, 2012
Progression following neoadjuvant systemic chemotherapy may not be a contraindication to a curative approach for colorectal carcinomatosisGuillaume Passot, Delphine Vaudoyer, Eddy Cotte, et al.
European Journal of Cancer (Oxford, England : 1990)|September 4, 2019
Clinical efficacy of the optimal biological dose in early-phase trials of anti-cancer targeted therapiesPauline Corbaux, Mévidette El-Madani, Michel Tod, et al.
Pageof 15

Showing results (21-30 of 141) with videos related to

Sort By:
Pageof 15
Bulletin Du Cancer|June 20, 2017
Anne Floquet, Dominique Berton-Rigaud, Gwenael Ferron, et al.
Anticancer Research|December 1, 2017
Modeling CA-125 During Neoadjuvant Chemotherapy for Predicting Optimal Cytoreduction and Relapse Risk in Ovarian CancerSimon Ducoulombier, François Golfier, Olivier Colomban, et al.
Gynecologic and Obstetric Investigation|September 13, 2023
Immunotherapy for Gestational Trophoblastic Neoplasia: A New ParadigmInge O Baas, Anneke M Westermann, Benoit You, et al.
Anti-Cancer Drugs|December 11, 2012
Influence of statistician involvement on reporting of randomized clinical trials in medical oncologyJulien Péron, Benoit You, Hui K Gan, et al.
Cancers|February 15, 2022
Modeled Early Longitudinal PSA Kinetics Prognostic Value in Rising PSA Prostate Cancer Patients after Local Therapy Treated with ADT +/- DocetaxelAurore Carrot, Reza-Thierry Elaidi, Olivier Colomban, et al.
Annals of Surgical Oncology|February 8, 2023
ASO Author Reflections: Which is the Optimal Preoperative Systemic Chemotherapy Regimen for Patients with Peritoneal Metastases from Colorectal Cancer?Vahan Kepenekian, Amaniel Kefleyesus, Guillaume Passot, et al.
JCO Clinical Cancer Informatics|February 16, 2024
Prognostic Value of the Modeled Prostate-Specific Antigen KELIM Confirmation in Metastatic Castration-Resistant Prostate Cancer Treated With Taxanes in FIRSTANAAurore Carrot, Stéphane Oudard, Olivier Colomban, et al.
Annals of Surgical Oncology|June 5, 2015
Intraperitoneal Vascular Endothelial Growth Factor: A Prognostic Factor and the Potential for Intraperitoneal Bevacizumab Use in Peritoneal Surface MalignanciesClaramae Shulyn Chia, Olivier Glehen, Naoual Bakrin, et al.
Annals of Surgery|May 15, 2012
Progression following neoadjuvant systemic chemotherapy may not be a contraindication to a curative approach for colorectal carcinomatosisGuillaume Passot, Delphine Vaudoyer, Eddy Cotte, et al.
European Journal of Cancer (Oxford, England : 1990)|September 4, 2019
Clinical efficacy of the optimal biological dose in early-phase trials of anti-cancer targeted therapiesPauline Corbaux, Mévidette El-Madani, Michel Tod, et al.
Pageof 15